A phase Ib trial of CFI-402257 in combination with weekly paclitaxel in patients with advanced HER2-negative (HER2-) breast cancer (aBC)

Authors
Category Primary study
JournalANNALS OF ONCOLOGY
Year 2020
This article has no abstract
Epistemonikos ID: 9c84df748428140e6b72ecb78b82f6d0f66b6734
First added on: Feb 11, 2025